Ongoing patient self-management education and support using technology in diabetes are critical for achieving glycemic control and preventing complications.
My Dose CoachTM, is a mobile app combined with a web portal, that can suggest optimized basal insulin injection doses using fasting blood glucose and hypoglycemia data. The aim of this study was to evaluate its efficacy on patients reaching Fasting Plasma Glucose (FPG) target range 90-130 mg/dl (5-7.2 mmol/L) without severe hypoglycemic episodes (low glucose levels that required assistance) and the mean reduction in A1c.
This experimental study involved the use of My Dose CoachTM previously programed with a titration scheme according to fasting glucose in patients with type 2 diabetes that were treated with basal insulin in Clinica Nova in Monterrey, Mexico. We followed the patients for 16 weeks. Descriptive statistics and student t-tests were used when appropriate.
We included 158 patients (46.8% women), mean (SD) age 51 (10.3) years. One hundred forty-one completed the study (89%). We achieved the FBG goal in 70.9% of the patients [66(28) days], with no event of severe hypoglycemia; 40.5% had 1-9 events of mild-moderate hypoglycemic [58(8) mg/dl] that was successfully treated at home. The mean (95CI) reduction of A1C was 1.78% (1.47-2, p<0.01) with last observation carried forward.
My Dose Coach app successfully helped to achieve FBG, reduced A1c with no events of severe hypoglycemia in patients with type 2 diabetes being treated with basal insulin.